EpiVacCorona
EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVakKorona) is a COVID-19 vaccine developed by the Vector Institute.[1][2][3] The EpiVacCorona vaccine contains fragments extracted from the virus synthetic peptide antigens. The antigens-based vaccine provokes an immune reaction against COVID-19 and promotes the further development of immunity.[4]
| Vaccine description | |
|---|---|
| Target disease | COVID-19 |
| Type | Peptide |
| Clinical data | |
| Routes of administration | Intramuscular |
| Legal status | |
| Legal status |
|
| Identifiers | |
| DrugBank | |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg.png.webp){kind=small} COVID-19 Portal |
Description
EpiVacCorona is a peptide antigens-based vaccine.[5] Thus The vaccine does not contain the live virus and forms immunity due to the use of artificially synthesized peptides.[6]
Development
In March 2020 it was reported that Russian scientists have begun to test vaccine prototypes for the new coronavirus disease, with the plan of presenting the most effective one in June, a laboratory chief at Vector Institute said. The prototypes have been created and the testing on animals began.[7]
In July 2020, research by the center in found that the SARS-CoV-2 virus that causes COVID-19 can be killed in room temperature water within 72 hours, helping further research about the disease during the pandemic.[8][9]
Authorization
On 14 October 2020, President Vladimir Putin announced that the vaccine was approved.[10]
References
- "Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)". ClinicalTrials.gov. United States National Library of Medicine. 22 September 2020. NCT04368988. Retrieved 16 November 2020.
- "Russian EpiVacCorona Vaccine Has No Adverse Effects". OREANDA-NEWS. 13 January 2021.
- "Over 1,400 volunteers get Russia's first EpiVacCorona vaccine jab". TASS. 15 December 2020.
- "State Research Center of Virology and Biotechnology: COVID-19 Vaccine Patented". Federal Service for Intellectual Property. 30 September 2020. Retrieved 17 January 2021.
- Russia’s EpiVacCorona vaccine post-registration trials started. The Pharma Letter.
- https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started
- "Russia to test coronavirus vaccine prototype on animals". Retrieved 17 March 2020.
- "Scientists figure out a weakness of coronavirus: Ordinary water". mint. 1 August 2020. Retrieved 23 September 2020.
- "Water at boiling temperature can completely destroy novel coronavirus, say Russian scientists". www.timesnownews.com. Retrieved 23 September 2020.
- "Совещание с членами Правительства". President of Russia. 14 October 2020.
